SLD

SALUDA MED CDI FORUS [SLD]
Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeutic window. It also offers an application to sense, measure, and adjust the pulse. The company was founded in 2011 and is based in Bloomington, Minnesota.
Healthcare · ASX Small Cap
$0.5250 -1.9%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when SLD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track SLD — Free

Active Signals

Bullish Signals

  • Trading above both moving averages — the trend is your friend here
  • Beating the Small Ords index — relative strength of 1.30, so it's outpacing the pack
  • Adequate cash runway (5 quarters)
  • Moderate revenue growth (+17%)
  • Near 52-week low (11% of range)
  • CANSLIM I: Institutional ownership (31%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 67% over the past year
  • Poor risk-adjusted returns — Sharpe of -1.7 means lots of volatility for not much reward
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.34%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Stochastic turning bearish from a high level — caution
  • Deeply negative margins (-214%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about SLD
"What's driving SLD today?" "How does SLD compare to peers?" "Key risks for SLD?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE First U.S. Surgical Cases Using CAP24 Paddle Leads
NONE Change in substantial holding
NONE Notification of cessation of securities - SLD

Recent ASX Announcements

2026-07-16 First U.S. Surgical Cases Using CAP24 Paddle Leads
2026-07-13 Change in substantial holding
2026-07-12 Notification of cessation of securities - SLD
2026-07-12 Notification regarding unquoted securities - SLD
2026-06-30 Notification regarding unquoted securities - SLD

Key Metrics

N/A
Market Cap
661K
Avg Volume
0.7x
Vol Ratio
$0.36 — $1.90
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
N/A
ROE
-213.8%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual Earningsinsufficient_dataCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & Demandinsufficient_dataFloat: 0%
LLeader vs LaggardlaggardRS: -8
IInstitutional SponsorshippassInst: 31%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:SLD vs IDTSLD vs ADRSLD vs LDX
Scout Pro — Deeper Analysis for SLD
Try Pro free for 30 days
Share this analysis

Track SLD and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required